{"id":66826,"date":"2017-09-19T18:47:36","date_gmt":"2017-09-19T11:47:36","guid":{"rendered":"http:\/\/www.siamlandbank.com\/propertynews\/property-news\/gsk-wins-approval-for-three-in-one-inhaler-in-us\/"},"modified":"2017-09-19T19:03:25","modified_gmt":"2017-09-19T12:03:25","slug":"gsk-wins-approval-for-three-in-one-inhaler-in-us","status":"publish","type":"post","link":"https:\/\/www.siamlandbank.com\/propertynews\/property-news\/gsk-wins-approval-for-three-in-one-inhaler-in-us\/","title":{"rendered":"GSK wins approval for three-in-one inhaler in US"},"content":{"rendered":"<p>&#013;<br \/>\n&#013;<br \/>\n&#013;<br \/>\nSource : telegraph.co.uk&#013;<br \/>\nRead more&#8230;<a href=\"http:\/\/www.telegraph.co.uk\/business\/2017\/09\/19\/gsk-wins-approval-three-in-one-inhaler-us\/\" target=\"_blank\">GSK wins approval for three-in-one inhaler in US<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#013; &#013; &#013; Source : telegraph.co.uk&#013; Read more&#8230;GSK wins approval for three-in-one inhaler in US<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","footnotes":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true},"categories":[1],"tags":[],"class_list":["post-66826","post","type-post","status-publish","format-standard","hentry","category-property-news"],"jetpack_featured_media_url":"","jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p75ss1-hnQ","jetpack-related-posts":[{"id":66490,"url":"https:\/\/www.siamlandbank.com\/propertynews\/property-news\/gsk-fightback-in-lung-drugs-boosted-by-three-in-one-inhaler-endorsement\/","url_meta":{"origin":66826,"position":0},"title":"GSK fightback in lung drugs boosted by three-in-one inhaler endorsement","date":"September 15, 2017","format":false,"excerpt":"\r \r \r Source : telegraph.co.uk\r Read more...GSK fightback in lung drugs boosted by three-in-one inhaler endorsement","rel":"","context":"In &quot;Property News&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":72003,"url":"https:\/\/www.siamlandbank.com\/propertynews\/property-news\/gsk-to-launch-three-in-one-inhaler-in-uk-early-next-year\/","url_meta":{"origin":66826,"position":1},"title":"GSK to launch three-in-one inhaler in UK early next year","date":"November 16, 2017","format":false,"excerpt":"\r \r \r Source : telegraph.co.uk\r Read more...GSK to launch three-in-one inhaler in UK early next year","rel":"","context":"In &quot;Property News&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":83307,"url":"https:\/\/www.siamlandbank.com\/propertynews\/property-news\/inhaler-maker-vectura-targets-more-gsk-best-sellers-after-100m-loss\/","url_meta":{"origin":66826,"position":2},"title":"Inhaler maker Vectura targets more GSK best-sellers after \u00a3100m loss","date":"March 21, 2018","format":false,"excerpt":"\r \r \r Source : telegraph.co.uk\r Read more...Inhaler maker Vectura targets more GSK best-sellers after \u00a3100m loss","rel":"","context":"In &quot;Property News&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":72535,"url":"https:\/\/www.siamlandbank.com\/propertynews\/property-news\/gsk-gets-boost-as-first-two-drug-regimen-for-hiv-gets-us-approval\/","url_meta":{"origin":66826,"position":3},"title":"GSK gets boost as first two-drug regimen for HIV gets US approval","date":"November 22, 2017","format":false,"excerpt":"\r \r \r Source : telegraph.co.uk\r Read more...GSK gets boost as first two-drug regimen for HIV gets US approval","rel":"","context":"In &quot;Property News&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":84113,"url":"https:\/\/www.siamlandbank.com\/propertynews\/property-news\/us-court-overturns-gsk-drug-patent-verdict-to-rule-in-tevas-favour\/","url_meta":{"origin":66826,"position":4},"title":"US court overturns GSK drug patent verdict to rule in Teva&#039;s favour","date":"March 29, 2018","format":false,"excerpt":"\r \r \r Source : telegraph.co.uk\r Read more...US court overturns GSK drug patent verdict to rule in Teva's favour","rel":"","context":"In &quot;Property News&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":79406,"url":"https:\/\/www.siamlandbank.com\/propertynews\/property-news\/gsk-sues-us-rival-over-alleged-hiv-drug-patent-infringement\/","url_meta":{"origin":66826,"position":5},"title":"GSK sues US rival over alleged HIV drug patent infringement","date":"February 8, 2018","format":false,"excerpt":"\r \r \r Source : telegraph.co.uk\r Read more...GSK sues US rival over alleged HIV drug patent infringement","rel":"","context":"In &quot;Property News&quot;","img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/www.siamlandbank.com\/propertynews\/wp-json\/wp\/v2\/posts\/66826"}],"collection":[{"href":"https:\/\/www.siamlandbank.com\/propertynews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.siamlandbank.com\/propertynews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.siamlandbank.com\/propertynews\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.siamlandbank.com\/propertynews\/wp-json\/wp\/v2\/comments?post=66826"}],"version-history":[{"count":0,"href":"https:\/\/www.siamlandbank.com\/propertynews\/wp-json\/wp\/v2\/posts\/66826\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.siamlandbank.com\/propertynews\/wp-json\/wp\/v2\/media?parent=66826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.siamlandbank.com\/propertynews\/wp-json\/wp\/v2\/categories?post=66826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.siamlandbank.com\/propertynews\/wp-json\/wp\/v2\/tags?post=66826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}